News from the world
22
May
5 Emerging Trends In Complex Small Molecule Drug Production
Product development of new generic molecules starts early in the life cycle of the originator product (at the time of market launch), so long-term planning is essential and mainly based on product patent expiries. For small molecule generics, the development and manufacturing processes are in most cases straightforward...[OutsourcedPharma]
18
Carenze di farmaci. EMA pubblica 10 raccomandazioni per le aziende
La guida descrive le varie parti interessate nella catena di approvvigionamento dei medicinali, le loro...
Report Egualia: Generici, mercato fermo al palo, si rischia che questi farmaci spariscano
Ancora un anno sospeso tra stagnazione e depressione per il mercato italiano dei generici-equivalenti...
17
Carenze farmaci: una proposta per tornare al “Made in Europe” e ridurre la dipendenza dai fornitori (come Cina e India)
After the European Commission proposed a massive overhaul to the EU’s drug legislation,...
12
EDQM - Requirements for the content of the CEP dossier according to the CEP 2.0 and updated application forms
As part of the implementation of the CEP 2.0, some changes regarding the content of CEP applications...
latest news
22 May
18 May
17 May
12 May
11 May
US FDA - Testing of Glycerin, Propylene Glycol, Maltitol Solution, Hydrogenated Starch Hydrolysate, Sorbitol Solution, and other High-Risk Drug Components for Diethylene Glycol and Ethylene Glycol
FDA Issues Discussion Paper on Artificial Intelligence and Machine Learning in Drug Development
08 May
Covid-19, Ministero Salute: “Da oggi possiamo dire che l’emergenza sanitaria Covid-19 è alle nostre spalle”
1 2>>>
